The FDA has extended the deadline for drug and device manufacturers, distributors, and others to comply with enhanced drug distribution security requirements under the Drug Supply Chain Security Act (DSCSA). Originally set for November 27, 2023, the new enforcement...

The Centers for Medicare & Medicaid Services (CMS) have chosen the first 10 prescription drugs for price negotiations under the Inflation Reduction Act. These drugs include various medications like apixaban, empagliflozin, rivaroxaban, sitagliptin, dapagliflozin,...

The pharmaceutical industry is grappling with drug shortages, and it's crucial to address this issue through strategies, technologies, and regulations.

Manufacturers need to embrace cutting-edge technologies, such as digital twins for predictive maintenance, AI for...

Medication adherence plays a crucial role in enhancing health outcomes. The Centers for Disease Control and Prevention (CDC) highlights its impact on managing chronic diseases and reducing mortality. However, many individuals are not following prescribed medication...

In a world that's gradually moving beyond the pandemic, the pharmacy sector is preparing for another significant disruption. The Centers for Medicare and Medicaid Services (CMS) are set to change the way Direct and Indirect Remuneration (DIR) fees are applied....

In the past, going to a pharmacy for medication often meant uncertainty about costs and insurance coverage, leading to anxiety when receiving bills you couldn't afford. Pharmacies used to extend credit, creating difficulties for both patients and pharmacies....

An epidemic of loneliness is affecting a significant portion of Americans, with 60% impacted overall, including 75% of young adults and 40% of older adults. Loneliness is linked to mental and physical health disorders, treatment adherence, and hospitalizations.

The...

Pharmacists are well-informed about the impending Direct and Indirect Remuneration (DIR) fee changes set to begin in 2024. The Center for Medicare and Medicaid Services (CMS) has finalized a rule to eliminate the retroactive application of DIR fees by pharmacy...